Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer
Jinfeng Zhou1,2, Jianjun Yang1, Xing Fan3
1a State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Diseases , Fourth Military Medical University , Xi'an , China.
Abstract:
LAMP2A is the key protein of chaperone-mediated autophagy (CMA), downregulation of LAMP2A leads to CMA blockade. CMA activation has been implicated in cancer growth, but the exact mechanisms are unclear. Elevated expression of LAMP2A was found in 8 kinds of tumors (n=747), suggesting that LAMP2A may have an important role in cancer progression. Unsurprisingly, LAMP2A knockdown in gastric cancer (GC) cells hindered proliferation, accompanied with altered expression of cell cycle-related proteins and accumulation of RND3/RhoE. Interactomic and KEGG analysis revealed that RND3 was a putative CMA substrate. Further study demonstrated that RND3 silencing could partly rescue the proliferation arrest induced by LAMP2A knockdown; RND3 was increased upon lysosome inhibition via both chemicals and LAMP2A-shRNA; Furthermore, RND3 could interact with CMA components HSPA8 and LAMP2A, and be engulfed by isolated lysosomes. Thus, constant degradation of RND3 by CMA is required to sustain rapid proliferation of GC cells. At last, the clinical significance of LAMP2A was explored in 593 gastric noncancerous lesions and 173 GC tissues, the results revealed that LAMP2A is a promising biomarker for GC early warning and prognosis of female GC patients.
Insights
Chaperone-mediated autophagy (CMA) protein LAMP2A promotes gastric cancer growth by degrading RND3. Inhibiting LAMP2A or RND3 hinders cancer proliferation, suggesting LAMP2A as a potential biomarker for early gastric cancer detection.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Chaperone-mediated autophagy (CMA) is crucial for cellular protein degradation.
- LAMP2A is the key protein regulating CMA activity.
- CMA dysregulation is linked to cancer, but mechanisms remain unclear.
Purpose of the Study:
- To elucidate the role of LAMP2A in gastric cancer (GC) progression.
- To identify molecular mechanisms linking LAMP2A to GC growth.
- To evaluate LAMP2A as a potential biomarker for GC.
Main Methods:
- LAMP2A knockdown in gastric cancer cells.
- Analysis of cell proliferation and cell cycle-related proteins.
- Interactomic and KEGG pathway analysis.
- Investigation of RND3 as a CMA substrate.
- Clinical tissue analysis of LAMP2A expression.
Main Results:
- LAMP2A knockdown inhibited GC cell proliferation and altered cell cycle proteins.
- RND3/RhoE accumulated upon LAMP2A downregulation or lysosome inhibition.
- RND3 was identified as a CMA substrate, interacting with HSPA8 and LAMP2A.
- RND3 degradation by CMA is essential for GC cell proliferation.
- Elevated LAMP2A expression in multiple tumors, including GC.
- LAMP2A shows potential as an early warning biomarker and prognostic indicator for female GC patients.
Conclusions:
- LAMP2A-mediated CMA is vital for sustaining gastric cancer cell proliferation through RND3 degradation.
- LAMP2A represents a promising biomarker for early gastric cancer detection and prognosis, particularly in females.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Abnormal Proliferation
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

